65,437 trials
Seasonal Affective Disorder
Primary: Sleep Satisfaction at Baseline and Measured Monthly, as Measured by the Pittsburgh Sleep Quality Index (PSQI) — 11.56; 11.45; 9.52; 8.67 scores on a scale
Schizophrenia
Primary: Change in Positive and Negative Syndrome Scale (PANSS) Total Score From Baseline to Week 13 or the Last Post-baseline Assessment — -8.0; -11.6; -13.2; -2.9 Scores on a…
Major Depressive Disorder
Primary: Change From Baseline to 4 Week Endpoint in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score — 36.1; 36.0; -20.1; -19.9 units on a scale — p=0.88
Chronic Hepatitis B
Primary: Number of Participants Achieving HBV DNA (Hepatitis B Virus Deoxyribonucleic Acid) <1000 Copies/Milliliter at Week 48 — 341; 243; 584; 767 participants
Chronic Hepatitis B
Primary: Number of Participants Achieving HBV DNA ≤300 Copies/mL at Week 104 — 85; 403 participants
Chronic Allergic Rhinitis · Nonallergic Rhinitis
Primary: Number of Participants Reporting Adverse Events — 207; 211 Participants
Macular Degeneration
Primary: Number of Responders for Visual Acuity Using Early Treatment Diabetic Retinopathy Study (ETDRS) — 40; 7; 33 participants
Generalized Anxiety Disorder · Panic Disorder
Primary: Cumulative Percent of Participants Showing a Response in the Symptoms of Anxiety (Decrease in Total Hamilton Anxiety (HAM-A) -Score of >=50%) in the Intent-to-treat…
Cataract Extraction
Primary: Resolution of Post Operative Inflammation — 58.0; 27.3 % of participants with a score of 0
Heartburn
Primary: Complete Heartburn Relief During the First Full 24-Hour Period in the ITT Population. — 114; 163 participants — p=<0.001
Cataract Extraction · Pain · Inflammation
Primary: Resolution of Post Operative Inflammation — 46.3; 25.6 % of participants with a score of 0
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 12,344.00; 10,940.05 ng/mL
Rhinitis, Allergic, Perennial
Primary: Comparison of Mean Change From Baseline in Daily Reflective Total Nasal Symptom Score (rTNSS) Over Treatment Periods of Active Drug Nasal Sprays Versus Placebos — -2.7…
Osteoporosis
Primary: Percent Change in Bone Mineral Density at Lumbar Spine (L2-L4) — 9.82; 0.04 percent change in BMD — p=<0.001
Schizophrenia · Schizoaffective Disorders
Primary: Change From Baseline to Endpoint in Weight — 2.76; 2.40; 0.65 kilograms — p=0.065